Role of Bcl-xL protein in differentiation and apoptosis of human middle ear cholesteatoma epithelium

Archives of Otolaryngology - Head and Neck Surgery

Volumn 125, Issue 7, 1999, Pages 738-742

  Kojima, Hiromi ^a   Miyazaki, Hidemi ^b   Tanaka, Yasuhiro ^a   Sjitwa, Masanori ^b   Koga, Tomohiko ^a   Moriyama, Hiroshi ^a,c  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Chiba Social Insurance Hospital   (Japan)

^c Hosei University   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; INVOLUCRIN; PROTEIN BCL X;

ADULT; AGED; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CHOLESTEATOMA; CLINICAL ARTICLE; CONTROLLED STUDY; EPITHELIUM; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MALE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTO ONCOGENE;

EID: 0032765061     PISSN: 08864470     EISSN: None     Source Type: Journal    
DOI: 10.1001/archotol.125.7.738     Document Type: Article

References (30)

1. Bujia J, Holly A, Schilling V, Negri B, Pitzke P, Schulz P. Aberrant expression of epidermal growth factor receptor in aural cholesteatoma. Laryngoscope. 1993; 103:326-329.
2. Mayot D, Bene MC, Perrin C, Faure GC. Restricted expression of Ki-67 in cholesteatoma epithelium. Arch Otolaryngol Head Neck Surg. 1993;119:656-658.
3. Ergun S, Zheng X, Carlsoo B. Antigen expression of epithelial markers, collagen IV and Ki-67 in middle ear cholesteatoma: an immunohistochemical study. Acta Otolaryngol (Stockh). 1994:114:295-302.
4. Kojima H, Shiwa M, Kamide Y, Moriyama H. Expression and localization of mRNA for epidermal growth factor and epidermal growth factor receptor in human cholesteatoma. Acta Otolaryngol (Stockh). 1994;114:423-429.
5. Shilling V, Lang S, Rasp G, Mack B, Nerlich A. Overexpression of tenascin in cholesteatoma and external auditory meatal skin compared to retroauricular epidermis. Acta Otolaryngol (Stockh). 1996:116:741-746.
6. Kim TT, Chen CT, Huang CC. Expression of annexin II in human middle ear cholesteatoma. Otolaryngol Head Neck Surg. 1998;118(pt 1):324-328.
7. Kojima H, Matsuhisa A, Shiwa M, et al. Expression of messenger RNA for keratinocyte growth factor in human cholesteatoma. Arch Otolaryngol Head Neck Surg. 1996:122:157-160.
8. Tanaka Y, Shiwa M, Kojima H, Miyazaki H, Kamide Y, Moriyama H. A study on epidermal proliferation ability in cholesteatoma. Laryngoscope. 1998;108{pt 1 ): 537-542.
9. Shiwa M, Kojima H, Moriyama H. Expression of transforming growth factor-a (TGF-a) in cholesteatoma. J Laryngol Otol. 1998:112:750-754.
10. Kojima H, Tanaka Y, Tanaka T, et al. Cell proliferation and apoptosis in human middle ear cholesteatoma. Arch Otolaryngol Head Neck Surg. 1998:124:261264.
11. Chao WY, Huang CC. An immunocytochemical study ol cytokeratin expression in human middle ear cholesteatoma. Arch Otorhinolaryngol. 1989:246:37-42.
12. Bujia J. Shilling V, Holly A, Stammberger M, Kastenbauer E. Hyperproliferationassociated keratin expression in human middle ear cholesteatoma. Acta Otolaryngol (Stockh). 1993:113:364-368.
13. Hockenbery D, Zutter M, Mickey W, Nahm M, Korsmeyer SJ. Bcl-2 protein is an inner mitochondrial membrane protein that blocks topographically programmed cell death. Nature. 1990:348:334-336.
14. Veis DJ, Sorenson CM, Shutter JR, KorsmeyerSJ. Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell. 1993:75:229-240.
15. Datta R, Manome Y, Taneja N, et al. Overexpression of Bcl-xi by cytotoxic drug exposure confers resistance to ionizing radiation-induced intemucleosomal DMA fragmentation. Cell Grov/th Differ. 1995:6:363-370.
16. Kojima H, Endo K, Moriyama H, et al. Abrogation of mitochondrial cytochrome C release and caspase-3 activation in acquired multidrug resistance. JBiolChem. 1998:273:16647-16650.
17. Datta R, Banach D, Kojima H, et al. Activation of the CPP32 protease in apoptosis induced by 1 D-arabinofuranosylcytosine and other DNA-damaging agents. Blood. 1996:88:1936-1943.
18. Ergun S, Zheng X, Carlsoo B. Expression of transforming growth factor-a and epidermal growth factor receptor in middle ear cholesteatoma. Am J Otol. 1996; 17:393-396.
19. Ojala S. Pathogenesis of middle ear cholesteatoma arising from Sharpnell's membrane (attic cholesteatoma). Acta Otolaryngol (Stockh). 1951 ;101:33-54.
20. Ruedi L Acquired cholesteatoma. Arch Otolaryngol. 1963:72:252-261.
21. Shiwa M, Kojima H, Kamide Y, Moriyama H. Involvement of interleukin-1 in middle ear cholesteatoma. Am J Otolaryngol. 1995;16:319-324.
22. Fuchs E. Epidermal differentiation. CurrOpin CellB/ol. 1990:2:1028-1035.
23. Jones PH, Harper S, Watt FM. Stem cell patterning and fate in human epidermis. Cell. 1995:80:83-93.
24. Hockenbery DM, Zutter M, Hickey W, Nahm M, Korsmeyer SJ. BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc NatlAcad Sei U S A1 991 ;88:6961 -6965.
25. Rodriguez-Villanueva J, Colome Ml, Brisbay S, McDonnell TJ. The expression and localization of bcl-2 protein in normal skin and in non-melanoma skin cancers. Palhol Res Pract. 1995:191:391-398.
26. Boise LH, Gonzalez-Garcia M, Postema CE, et al. teAx, a icA2-related gene that functions as a dominant regulator of apoptotic cell death. Ce/1.1993;74:597608.
27. Watt FM, Green H. Involucrin synthesis is correlated with cell size in human epidermal cultures. J Cell Biol. 1981:90:738-742.
28. Ishida-Yamamoto A, lizuka H. Differences in involucrin immunolabeling within cornified cell envelopes in normal and psoriatic epidermis. J Invest Dermatol. 1995:104:391-395.
29. Stammberger M, Bujia J, Kastenbauer E. Alteration of epidermal differentiation in middle ear cholesteatoma. Am J Otol. 1995;16:527-531.
30. Harada H, Mitsuyasu T, Seta Y, Maruoka Y, Toyoshima K, Yasumoto S. Overexpression of bcl-2 protein inhibits terminal differentiation ol oral keratinocytes in vitro. J Oral Pathol Med. 1998;27:11 -17.